vaccine development

Manufacturing

Catalent paused work on a British biologics plant

Contract manufacturing major Catalent is wrapping up regulatory problems at plants in Europe and the U.S. as it winds down work on another in the U.K.
Fraiser Kansteiner Nov 29, 2022 9:01am

Sanofi and GSK finally clinch COVID-19 vaccine success in EU

Nov 10, 2022 2:22pm

AstraZeneca withdraws US COVID vaccine application

Nov 10, 2022 9:55am

GSK weds its medicines and vaccine businesses from the top down

Oct 25, 2022 2:44pm

GSK's Shingrix offers 10 years of protection for older adults

Oct 19, 2022 11:46am

BioNTech plants research and production flag in Australia

Oct 7, 2022 10:11am